Search clinical trials for: Mycophenolic Acid

Total 24190 results

University of Texas Southwestern Medical Center
Aspreva Pharmaceuticals

Completed

Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple Sclerosis

Multiple Sclerosis

United States
Nova Scotia Health Authority

Completed

Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation

Acute Rejection of Renal Transplant

Canada
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

Heart Transplantation

United States, Australia, Argentina, Canada
Hikma Pharmaceuticals LLC

Completed

Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan (MyOra-PASS)

Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant

Jordan
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Renal Transplantation

United States, Germany, United Kingdom, Belgium, Australia, Hungary, Netherlands, Sweden, Colombia, Argentina, Brazil, Canada, Denmark, Korea, Republic of, Portugal
Martin, Paul
National Cancer Institute (NCI)

Terminated

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Cancer

United States, Canada
Novartis Pharmaceuticals

Completed

Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate

Autoimmune Disease

Germany
Novartis

Completed

Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus

Prevention of Acute Rejection After Kidney Transplantation
Novartis

Completed

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301

Renal Transplant
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fasting Conditions

Healthy

Canada
National Institutes of Health Clinical Center (CC)

Completed

Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers

Healthy

United States
University Hospital Muenster
Novartis

Completed

Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

Primary Sjogren's Syndrome

Germany
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil 250 mg Capsules Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mycophenolate Mofetil Tablets Under Fed Conditions

Healthy

Canada
The University of Hong Kong
Queen Mary Hospital, Hong Kong; United Christian Hospital

Completed

Mycophenolate Mofetil for IgA Nephropathy

IGA Nephropathy

China
Lindenwood University
NNB Nutrition

Completed

A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion (BBA)

Absorption; Chemicals

United States
Galmed Medical Reserch

Completed

A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male Volunteers

Healthy

Israel
Mirum Pharmaceuticals, Inc.

Completed

Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis

Bile Acid Synthesis Defect

United States
University of South Florida
National Cancer Institute (NCI); Children's Oncology Group

Completed

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Sarcoma | Lymphoma | Kidney Cancer | Leukemia | Neurotoxicity | Peripheral Neuropathy

United States
East Carolina University
Novartis Pharmaceuticals

Completed

Reducing Donor Specific Antibody (DSA) Strength in Maintenance Kidney Transplant Recipients (DSA Study)

Transplant; Failure, Kidney

United States
Novartis Pharmaceuticals

Completed

A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

Renal Transplantation
Guy's and St Thomas' NHS Foundation Trust
Institute of Child Health, University College London, London, UK.

Completed

Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) (MISSILE)

Systemic Lupus Erythematosus | Atherosclerosis

United Kingdom
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

De Novo Kidney Transplant Recipients
Novartis

Completed

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
University Health Network, Toronto

Unknown

Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors (MOTOR-MPA)

Organ Transplantation

Canada
University of Toronto

Completed

Protein Requirements in Male and Female Endurance Athletes

Healthy | Increased Metabolic Requirement

Canada
Vedic Lifesciences Pvt. Ltd.

Completed

Clinical Study to Evaluate Safety and Efficacy of Amino Acid in Healthy Individuals

Safety and Efficacy

India
University of Toronto
Ajinomoto Co., Inc.

Completed

Protein Requirements In Active Female Populations

Healthy | Increased Metabolic Requirement
Institut de Médecine et d'Epidémiologie Appliquée...

Completed

Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults (PHACO)

Obesity

France
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells

Idiopathic Inflammatory Myopathy | Interstitial Lung Disease

China
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)

Kidney Maintenance Transplant
Seoul National University Hospital
Chong Kun Dang Pharmaceutical

Completed

Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

Nephrotic Syndrome

Korea, Republic of
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Renal Transplantation
University of Michigan
Hoffmann-La Roche

Completed

Pharmacokinetics of Mmf and Valganciclovir

Kidney Transplant Recipient | Heart Transplant Recipient

United States
Novartis

Completed

Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Renal Transplantation
Novartis

Completed

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals

Completed

Freedom Study: Myfortic in Kidney Transplant Patients

Kidney Transplantation

Spain, United Kingdom, Taiwan, Australia, United States, Canada, Singapore, Malaysia, Germany, Argentina, Brazil, Italy, New Zealand
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Unknown

Lysine Metabolic Availability in Children

Children

Canada
Mirum Pharmaceuticals, Inc.
Children's Hospital Medical Center, Cincinnati

Completed

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

Cholestasis | Peroxisomal Disorders | Adrenoleukodystrophy | Zellweger Syndrome | Infantile Refsum's Disease

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Breast Neoplasms | Arthralgia

United States
Armed Forces Institute of Urology, Rawalpindi

Completed

COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI

Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi

Pakistan
University Hospital, Limoges

Completed

Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid. (PEMPA)

Autoimmune Bullous Dermatose

France
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms

Renal Transplant

Korea, Republic of
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
University of Cincinnati
Children's Hospital Medical Center, Cincinnati

Terminated

Study of Bile Acids in Patients With Peroxisomal Disorders

Adrenoleukodystrophy | Zellweger Syndrome | Infantile Refsum's Disease | Bifunctional Enzyme Deficiency
Third Affiliated Hospital, Sun Yat-Sen University
Beijing Friendship Hospital; Beijing YouAn Hospital; RenJi Hospital; Huashan Hospital and other collaborators

Recruiting

Long-term Benefit of MPA in Liver Transplantation

Liver Transplant Rejection | Immunosuppressant Adverse Reaction

China
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

IGA Nephropathy

China
Hoffmann-La Roche
Aspreva Pharmaceuticals

Completed

A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.

Myasthenia Gravis Generalised

France, Ukraine, Germany, United States, Italy, United Kingdom, Former Serbia and Montenegro
Hoffmann-La Roche

Completed

A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)

Lupus Nephritis

United States, Colombia, Israel, Brazil, Argentina, Costa Rica, France, Italy, Mexico, Panama, Peru, Spain
University of Wisconsin, Madison

Terminated

Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation

Renal Transplantation | Acute Rejection

United States

Search clinical trials for: Mycophenolic Acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations